However, our result is consistent with the impact of NAT2 polymorphisms in the study by Cabaleiro et al. (2014) reporting an increased incidence of RIS-induced headache among NAT2 IM and PM healthy individuals in comparison to NAT2 NMs. The gene discussed is NAT2; the disease is Headache.